Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-04 Sale | 2026-08-05 4:10 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks | 26,842 | $10.23 | $274,596 | 844,895 (Direct) | View |
| 2026-08-03 Sale | 2026-08-04 4:45 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks | 12,415 | $10.05 | $124,722 | 871,737 (Direct) | View |
| 2026-07-09 Sale | 2026-07-14 5:04 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks | 58,333 | $12.64 | $737,410 | 884,152 (Direct) | View |
| 2026-06-30 Sale | 2026-07-02 4:07 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 6,566 | $14 | $91,924 | 75,131 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 4:38 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 9,810 | $12 | $117,720 | 72,402 (Direct) | View |
| 2026-06-22 Sale | 2026-06-23 4:19 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks | 114,746 | $10.47 | $1,200,851 | 942,485 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 4:48 pm | 4D Molecular Therapeutics Inc. | FDMT | Kirn David See Remarks | 1,922 | $10.02 | $19,258 | 1,057,231 (Direct) | View |
| 2026-03-20 Sale | 2026-03-24 6:30 pm | 4D Molecular Therapeutics Inc. | FDMT | Gupta Ashoo VP, Finance and Controller | 390 | $8.61 | $3,358 | 62,261 (Direct) | View |
| 2025-12-20 Sale | 2025-12-23 9:05 pm | 4D Molecular Therapeutics Inc. | FDMT | Gupta Ashoo VP, Finance and Controller | 389 | $8.68 | $3,377 | 62,651 (Direct) | View |
| 2025-12-16 Sale | 2025-12-19 4:10 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $10.9 | $17,822 | 77,189 (Direct) | View |
| 2025-11-17 Sale | 2025-11-19 9:53 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $10.59 | $17,315 | 78,824 (Direct) | View |
| 2025-10-24 Sale | 2025-10-27 6:19 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 2,678 | $12 | $32,136 | 12,889 (Direct) | View |
| 2025-10-16 Sale | 2025-10-20 7:51 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $10.17 | $16,628 | 82,053 (Direct) | View |
| 2025-10-09 Sale | 2025-10-14 4:04 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 2,408 | $10 | $24,080 | 5,188 (Direct) | View |
| 2025-09-23 Sale | 2025-09-26 9:50 pm | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 2,407 | $8 | $19,256 | 7,596 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-30 Exercise | 2026-07-02 4:07 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 5,752 | $6.49 | 75,131 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:07 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 6,566 | $0 | 75,131 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 4:07 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 814 | $4.14 | 75,131 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:38 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 9,810 | $0 | 72,402 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:38 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 9,810 | $4.14 | 72,402 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:43 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:41 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:40 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:39 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:32 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:30 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | SBLENDORIO GLENN Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-18 5:28 pm | N/A 2036-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-03-25 Option Award | 2026-03-27 4:30 pm | N/A 2036-03-24 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2026-03-25 Option Award | 2026-03-27 4:30 pm | N/A 2036-03-24 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 217,000 | $0 | 217,000 (Direct) | View |
| 2026-03-25 Option Award | 2026-03-27 4:30 pm | N/A 2036-03-24 | 4D Molecular Therapeutics Inc. | FDMT | Simms Christopher Paul See Remarks | 219,000 | $0 | 219,000 (Direct) | View |
| 2026-03-20 Exercise | 2026-03-24 6:30 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Gupta Ashoo VP, Finance and Controller | 1,086 | $0 | 62,261 (Direct) | View |
| 2026-01-05 Option Award | 2026-01-07 9:12 pm | N/A 2036-01-04 | 4D Molecular Therapeutics Inc. | FDMT | SBLENDORIO GLENN Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2026-01-07 9:10 pm | N/A 2035-04-08 | 4D Molecular Therapeutics Inc. | FDMT | SBLENDORIO GLENN Director | 0 | $0 | 11,250 (Direct) | View |
| 2025-12-20 Exercise | 2025-12-23 9:05 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Gupta Ashoo VP, Finance and Controller | 1,086 | $0 | 62,651 (Direct) | View |
Ownership | 2025-12-19 4:12 pm | N/A 2034-10-07 | 4D Molecular Therapeutics Inc. | FDMT | Simms Christopher Paul See Remarks | 0 | $0 | 332,403 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-19 4:10 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $0 | 77,189 (Direct) | View |
| 2025-12-16 Exercise | 2025-12-19 4:10 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $4.14 | 77,189 (Direct) | View |
| 2025-12-12 Exercise | 2025-12-16 4:35 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 9,333 | $1.14 | 41,684 (Direct) | View |
| 2025-12-12 Exercise | 2025-12-16 4:35 pm | N/A 2026-03-09 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 9,333 | $0 | 41,684 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-11 4:18 pm | N/A 2035-12-08 | 4D Molecular Therapeutics Inc. | FDMT | Humer Kristian Chief Financial Officer | 480,000 | $0 | 480,000 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 9:53 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $0 | 78,824 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-19 9:53 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $4.14 | 78,824 (Direct) | View |
| 2025-10-24 Exercise | 2025-10-27 6:19 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,084 | $6.49 | 12,889 (Direct) | View |
| 2025-10-24 Exercise | 2025-10-27 6:19 pm | N/A 2032-06-17 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,084 | $0 | 12,889 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 7:51 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $0 | 82,053 (Direct) | View |
| 2025-10-16 Exercise | 2025-10-20 7:51 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 1,635 | $4.14 | 82,053 (Direct) | View |
Ownership | 2025-10-10 9:04 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | Gupta Ashoo VP, Finance and Controller | 0 | $0 | 97,796 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:05 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Chacko Jacob Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:05 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | GRAY SUSANNAH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:04 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Tomasello Shawn Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:04 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | THEUER CHARLES Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:04 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:03 pm | N/A 2035-06-16 | 4D Molecular Therapeutics Inc. | FDMT | MILLIGAN JOHN F Director | 33,750 | $0 | 33,750 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 8:00 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Bizily Scott Chief Legal Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 7:58 pm | N/A 2035-03-05 | 4D Molecular Therapeutics Inc. | FDMT | Kirn David Chief Executive Officer | 267,500 | $0 | 267,500 (Direct) | View |